Cancer molecular diagnostics firm Epigenomics plans to restructure its organization to increase its focus on the U.S. market. Early-stage product and technology research will be discontinued and clinical research scaled down. The firm expects to reduce its workforce by approximately 39 employees targeting a company size of 45 employees by year-end. Its second-generation blood test [...]

In a letter to federal regulators yesterday, Carlsbad, CA-based AutoGenomics withdrew its filing for an initial public offering, which the company submitted in July, 2008. The company said at that time that its IPO would be made only by means of a prospectus, with J.P. Morgan Securities Inc. acting as the sole book-running manager of the offering. CEO [...]

DUBLIN, May 17, 2011 /PRNewswire-FirstCall/ — Shire plc (LSE:SHP.l – News), the global specialty biopharmaceutical company, announces that it has signed an agreement to acquire Advanced BioHealing, Inc.   – Creation of a new strategic platform based on tissue regeneration using cell-based therapies complements Shire’s existing specialty focus and biologics manufacturing capability   – Strong [...]

The FDA warns a trio of companies that offer direct-to-consumer genetic tests on medical claims made in their marketing campaigns. The FDA formally warned three providers of direct-to-consumer DNA tests about medical claims the companies make that the federal watchdog agency hasn’t approved. The FDA wants the companies; American International Biotechnology Services, Lumigenix Inc and [...]

INDIANAPOLIS and PHILADELPHIA, Nov. 8, 2010 /PRNewswire-FirstCall/ — Eli Lilly and Company (NYSE:LLY – News) today announced that it has signed a definitive merger agreement to acquire Avid Radiopharmaceuticals, Inc., a privately held company developing novel molecular imaging compounds intended for the detection and monitoring of chronic human diseases. Avid’s lead program in development is [...]

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on the announcement by U.S. Treasury Secretary Geithner and Health and Human Services Secretary Sebelius of the recipients of the $1 billion Therapeutic Discovery Project: “Today’s announcement of Therapeutic Discovery Project (TDP) awards is an important first step toward the critical goals [...]

The Universidad Politécnica de Madrid’s Artificial Intelligence Group (LIA), based at the Facultad de Informática, has created a new DNA-based biological sensor that has potential applications in the field of genetic diagnostics. The basic sensor design was presented at the 2010 Conference on Unconventional Computation. The LIA group has submitted a patent application for the [...]

SAN DIEGO, Sept. 7 /PRNewswire/ — Zogenix, Inc. (“Zogenix”) announced today that it has filed a registration statement with the Securities and Exchange Commission (“SEC”) relating to the proposed initial public offering of shares of its common stock. The number of shares to be offered and the price range for the offering have not yet been [...]

“Abbott Laboratories will soon acquire the biggest share of India’s pharmaceuticals market, about 7%, when the company closes as early as next month on a $3.7 billion takeover of the drugs business of Piramal Healthcare Ltd.,” the Wall Street Journal reports in an article that examines how pharmaceutical companies are tapping into emerging markets as a [...]

By Steven Overly Monday, August 16, 2010 But plans to substantially expand the biological research and testing company are underway, both physically at the site and financially around the globe. Executives aim to double Qiagen‘s revenue to $2 billion over the next five years. That trajectory will require a mix of organic growth within the existing [...]